相关实验视频
Updated: May 27, 2025

10:17
The Tail Suspension Test
Published on: January 28, 2012
79.6K
立即释放与延长释放的配方在双相情感障碍:一个为期2年的比较研究
Margherita Barbuti1, Martina Moriconi1, Daria Bartolini1
1Psychiatry Unit 2, Department of Clinical and Experimental Medicine, University of Pisa.
International clinical psychopharmacology
|February 18, 2025
概括
这项研究比较了双相情感障碍 (BD) 的立即释放 (IR) 和延长释放 (PR) . PR的疗效与IR的疗效相似,但耐受性和坚持性更好,这表明它具有更好的效果.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 神经科学和心理健康
背景情况:
- 是双相情绪障碍 (BD) 的基石情绪稳定剂.
- 优化配方对于BD患者的长期治疗坚持和耐受性至关重要.
研究的目的:
- 为了比较双相情感障碍患者的立即释放 (IR) 和延长释放 (PR) 配方之间的治疗结果,耐受性和坚持.
- 评估IR与PR的两年临床疗效和安全性.
主要方法:
- 一项自然主义研究涉及143名双相情感障碍患者开始IR或PR治疗.
- 数据收集包括副作用,坚持,血水平和临床评估 (CGI-双极,FAST) 在2年的随访期间.
- 分析对两种配方之间的结果进行了比较,承认了观察设计和潜在混因素等局限性.
主要成果:
- 无论是IR和PR类组都显示出显著的临床改善,有效性相似.
- 与红外相比,PR具有更好的耐受性,报告的副作用 (例如震,胃肠道问题) 较少.
- 接受PR的患者表现出更好的治疗坚持和更稳定的血液水平监测.
结论:
- 延长释放 (PR) 配方的临床疗效与双相情感障碍的即时释放 (IR) 相提并论.
- PR提供了增强的耐受性和改善患者的坚持,使其成为一个有利的选择,特别是对于那些有停止治疗的风险的人.
- 这些发现支持PR作为治疗双相情感障碍的有价值的替代品,有可能改善长期治疗的成功.
相关概念视频
Mania and Antimanic Drugs: Overview
115
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
115
Bipolar Disorder
45
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
45
Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
71
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
71
Drug Therapy
35
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
35
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22

